HI
VKTX icon

Harbour Investments’s Viking Therapeutics VKTX Stock Holding History

Harbour Investments’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$642K Sell
16,451
-779
-5% -$25.2K 0.01% 1004
2026
Q1 		$561K Buy
17,230
+3,389
+24% +$109K 0.01% 999
2025
Q4 		$487K Sell
13,841
-620
-4% -$22K 0.01% 858
2025
Q3 		$380K Sell
14,461
-500
-3% -$14.9K 0.01% 929
2025
Q2 		$396K Buy
14,961
+326
+2% +$8.58K 0.01% 865
2025
Q1 		$353K Buy
14,635
+14,625
+146,250% +$462K 0.01% 860
2024
Q4 		$402 Hold
10
– – ﹤0.01% 3301
2024
Q3 		$633 Hold
10
– – ﹤0.01% 3169
2024
Q2 		$530 Hold
10
– – ﹤0.01% 3080
2024
Q1 		$820 Sell
10
-750
-99% -$33.4K ﹤0.01% 2967
2023
Q4 		$14.1K Hold
760
– – ﹤0.01% 2016
2023
Q3 		$8.41K Buy
760
+750
+7,500% +$10.7K ﹤0.01% 2096
2023
Q2 		$162 Hold
10
– – ﹤0.01% 2917
2023
Q1 		$167 Hold
10
– – ﹤0.01% 2886
2022
Q4 		$94 Hold
10
– – ﹤0.01% 2927
2022
Q3 		$0 Hold
10
– – ﹤0.01% 2837
2022
Q2 		$0 Buy
+10
New +$25 ﹤0.01% 2837
2021
Q4 		$0 Sell
10
-500
-98% -$2.8K ﹤0.01% 3679
2021
Q3 		$3K Buy
510
+4
+0.8% +$25 ﹤0.01% 3231
2021
Q2 		$3K Hold
506
– – ﹤0.01% 3289
2021
Q1 		$3K Buy
+506
New +$3.56K ﹤0.01% 3137

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Harbour Investments's VKTX Position: Q2 2026 in Review

Harbour Investments reduced its Viking Therapeutics (VKTX) stake by 4.5% in Q2 2026, selling an estimated $25.2K and leaving 16,451 shares worth $642K. The position accounts for 0.01% of the portfolio, ranked #1004.

Harbour Investments first reported a position in VKTX in Q1 2021 and has held it in 21 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Harbour Investments held 16,451 shares of Viking Therapeutics worth $642K as of Q2 2026.
  • Harbour Investments sold 779 Viking Therapeutics shares in Q2 2026, an estimated $25.2K.
  • Viking Therapeutics made up 0.01% of Harbour Investments's portfolio in Q2 2026, its #1004 holding.
  • Harbour Investments first reported a position in Viking Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.